BioVie Stockholders Approve Key Proposals at Annual Meeting
I'm PortAI, I can summarize articles.
BioVie Inc. held its annual stockholders' meeting on November 10, 2025, where key proposals were approved, including the election of directors, the appointment of EisnerAmper LLP as auditors, and an amendment to increase shares in the 2019 Omnibus Equity Incentive Plan. Analysts rate BIVI stock as a Buy with a $12.00 target, but Spark's AI Analyst indicates an Underperform rating due to financial challenges, high cash burn, and bearish technical indicators. BioVie currently has a market cap of $11.75M and an average trading volume of 216,774.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments